Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease

被引：3
|
作者：
Cherney, David Z. I. L. [1 ,7 ]
Bhatt, Deepak [2 ]
Szarek, Michael [3 ]
Sun, Franklin [4 ]
Girard, Manon J. [4 ]
Davies, Michael [4 ]
Pitt, Bertram [5 ]
Steg, Ph. Gabriel [6 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Mt Sinai Hlth Syst, Mt Sinai Heart, Icahn Sch Med, New York, NY USA
[3] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[4] Lexicon Pharmaceut Inc, The Woodlands, TX USA
[5] Univ Michigan, Ann Arbor, MI USA
[6] Univ Paris Cite, Hop Bichat, AP HP, INSERM U 1148, Paris, France
[7] Toronto Gen Hosp, 85 Univ Ave,8N 845, Toronto, ON M5G 2N2, Canada
来源：
DIABETES OBESITY & METABOLISM | 2023年 / 25卷 / 11期
关键词：
D O I：
10.1111/dom.15203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3410 / 3414
页数：5
相关论文
共 50 条
  • [1] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
    Deepak L.Bhatt
    四川生理科学杂志, 2020, 42 (04) : 391 - 391
  • [2] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
    Bhatt, Deepak L.
    Szarek, Michael
    Pitt, Bertram
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Cherney, David Z. I.
    Dwyer, Jamie P.
    Scirica, Benjamin M.
    Bailey, Clifford J.
    Diaz, Rafael
    Ray, Kausik K.
    Udell, Jacob A.
    Lopes, Renato D.
    Lapuerta, Pablo
    Steg, P. Gabriel
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02): : 129 - 139
  • [3] Albuminuria and chronic kidney disease progression in patients with type 2 diabetes mellitus
    Kawada, Tomoyuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (10) : 1062 - 1063
  • [4] Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease
    Cherney, David Z. I.
    Ferrannini, Ele
    Umpierrez, Guillermo E.
    Peters, Anne L.
    Rosenstock, Julio
    Powell, David R.
    Davies, Michael J.
    Banks, Phillip
    Agarwal, Rajiv
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1646 - 1657
  • [5] Associations of the TyG index with albuminuria and chronic kidney disease in patients with type 2 diabetes
    Li, Xiaonan
    Wang, Yuehui
    PLOS ONE, 2024, 19 (10):
  • [6] Albuminuria Is Associated with Rapid Chronic Kidney Disease Progression in Patients with Type 2 Diabetes
    Sohn, Tae Seo
    Oh, Su Jin
    Seok, Hannah
    Park, Ha Neul
    Lee, Jeong Eun
    Ko, Yoo Mi
    Son, Hyun Shik
    DIABETES, 2014, 63 : A575 - A575
  • [7] Effects of sotagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease stages 3 and 4
    Sridhar, Vikas S.
    Davies, Michael J.
    Banks, Phillip
    Girard, Manon
    Carroll, Amy K.
    Cherney, David Z. I.
    DIABETES OBESITY & METABOLISM, 2024,
  • [8] Effect of Sotagliflozin (SOTA) on Albuminuria in Patients With Type 2 Diabetes (T2D) and CKD
    Cherney, David
    Bhatt, Deepak L.
    Szarek, Michael
    Sun, Franklin W.
    Davies, Michael J.
    Pitt, Bertram
    Steg, Philippe Gabriel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
  • [9] Risk of Cardiovascular Hospitalization among Patients with Type 2 Diabetes, Chronic Kidney Disease, and Albuminuria
    Nichols, Gregory A.
    Deruaz-Luyet, Anouk
    Hauske, Sibylle J.
    Brodovicz, Kimberly G.
    DIABETES, 2017, 66 : A405 - A405
  • [10] SOTAGLIFLOZIN REDUCES STROKE OUTCOMES IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE
    Aggarwal, Rahul
    Bhatt, Deepak L.
    Szarek, Michael
    Davies, Michael
    Banks, Phillip
    Pitt, Bertram
    Steg, Philippe Gabriel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1733 - 1733
12345